Navigation Links
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
Date:5/17/2012

RARITAN, N.J., May 17, 2012 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the results of an investigational Phase 3 study suggesting NUCYNTA® ER (tapentadol) extended-release tablets were significantly more effective than placebo in providing pain management among adults with chronic moderate to severe, painful diabetic peripheral neuropathy (DPN). Results of the study were presented at the 31st Annual Scientific Meeting of the American Pain Society being held May 16-19 in Honolulu, Hawaii.

Diabetes affects nearly 26 million people in the United States(1)– and its prevalence is expected to grow significantly during the coming decades(2). Over time, people with diabetes can develop a type of nerve damage called neuropathy. Approximately 60 to 70 percent of people with diabetes have some form of neuropathy(3). The most common type is diabetic peripheral neuropathy, which causes pain or loss of feeling in the toes, feet, legs, hands, and arms.

The study found, among patients who had at least a one-point reduction in pain intensity during three weeks of treatment with tapentadol ER, those who continued on an optimized dose of tapentadol ER (100-250 mg twice daily) for an additional 12 weeks experienced significantly better pain control compared to those who switched to placebo(4). Treatment-emergent adverse events reported in 10 percent or more of tapentadol ER-treated patients during the double-blind maintenance period included nausea (21.1 percent) and vomiting (12.7 percent)(4).

"Painful DPN is a common and burdensome complication of diabetes, and controlling pain in people with DPN can be challenging," said Aaron I. Vinik, M.D., Ph.D., FCP, MACP, Director of Research and Neuroendocrine Unit at Strelitz Diabetes Center for Endocrine and Metabolic Disorders at Eastern Virginia Medical School, and lead investigator of the study. "These data suggest tapentadol ER provides a significant reduction in chronic pain in adult
'/>"/>

SOURCE Janssen Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
2. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
3. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
4. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
5. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
6. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
7. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
10. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
11. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Calif. , Aug. 27, 2014 /PRNewswire-iReach/ -- ... response system design, blended emergency medical training and ... (automated external defibrillator) training from the Department ... Army Reserve 81 st Regional Support ... and Investigations contract includes nationwide CPR/AED/First Aid training. ...
(Date:8/27/2014)... , Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... James H. Mackaness is scheduled to make an ... Conference at 2:55 p.m. Eastern Time on Wednesday, September 3, ... webcast of the investor presentation will be available in the ... About IRIDEX IRIDEX Corporation was ...
(Date:8/27/2014)... , Aug. 27, 2014   Auxilium Pharmaceuticals , Inc. ... biopharmaceutical company, today announced that certain members of the ... Healthcare Conference to be held September 8-10, 2014 in ... , Chief Executive Officer and President, is scheduled to ... portfolio at 10:55 a.m. ET on Wednesday, September 10, ...
Breaking Medicine Technology:Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 2Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 3Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 3
... , WASHINGTON, Dec. 11 Nabe News ... medicines are in development to fight diabetes. The report details a ... clinical trials and awaiting approval by the U.S. Food and Drug Administration. ... ( PhRMA ). , Diabetics do not produce or properly use ...
... R.I., Dec. 11 CVS Caremark (NYSE: CVS ... Vice President and Chief Human Resources Officer, effective January 1, ... his retirement. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO ) , ... has more than 30 years of human resources experience. ...
Cached Medicine Technology:183 New Medicines in Development for Diabetes 2CVS Caremark Names New Chief Human Resources Officer 2
(Date:8/27/2014)... 2014 What’s next for 14 year ... Annual Scripps National Spelling Bee? Sririam will visit Philadelphia ... internationally renowned Wills Eye Hospital.     , The teen from ... ophthalmologist one day. , Wills Eye Ophthalmologist-in-Chief, Dr. Julia ... latest hi-tech visual diagnostic testing. He will also ...
(Date:8/27/2014)... 2014 NC. SonaCare Medical, LLC, the ... record-setting sales of 15 HIFU devices over the past ... demand for the company’s ablation technology. , “It ... has achieved over the past year, especially since we ... been our most active sales period,” says Mike Klein, ...
(Date:8/27/2014)... (HealthDay News) -- A new study finds that continuous ... seniors with sleep apnea. CPAP is widely used ... condition in which the airway relaxes and narrows during ... to daytime drowsiness. CPAP keeps the ... a patient,s nose via a mask that is worn ...
(Date:8/27/2014)... (HealthDay News) -- Overconfident people are better at convincing ... and therefore are more likely to get promotions and ... researchers added that these "self-deceived" people are also more ... greater risks. And finally, people who underestimate themselves ... to the British researchers. Their findings were published Aug. ...
(Date:8/27/2014)... each receive $100,000 in funding to launch pilot programs ... for patients served by community health centers. The program ... and is part of the group,s effort to reach ... over receiving regular screening for colorectal cancer by 2018. ... are: Port Royal, South Carolina; New Haven, Connecticut; and ...
Breaking Medicine News(10 mins):Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:SonaCare Medical Announces Twelve Months Sales Results of Fifteen HIFU Devices 2Health News:Sleep Apnea Treatment Helps Seniors, Study Finds 2Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 3
... October 18, 2011The U.S. health care system scored 64 ... to the third national scorecard report from the Commonwealth ... today. The scorecard finds thatdespite pockets of improvementthe U.S ... best performers in this country, and among other nations. ...
... 2011 Family matters, especially when it comes to ... at Wake Forest Baptist Medical Center, researchers found that ... kidney transplants, as compared to Caucasians. , The retrospective ... journal Clinical Transplantation, compared medical records of ...
... , TUESDAY, Oct. 18 (HealthDay News) -- Parents of ... chemotherapy rather than pursue supportive end-of-life care, researchers have found. ... choice, the health care professionals treating these very sick children ... alone to alleviate their patients, discomfort, according to the report ...
... vaccine developed by researchers at the University of Pennsylvania,s ... veterinary cancer vaccine of its kind that shows an ... lymphoma. The work shows for the first time the ... which could be employed in the treatment of a ...
... COLUMBIA, Mo. America,s elderly population will nearly double ... baby boomers enter retirement, concern exists as to who ... have accepted the caregiving responsibilities, but those caregiving roles ... divorce and remarriage than in previous decades. Now, University ...
... Denise Mann HealthDay Reporter , TUESDAY, Oct. ... it comes to treating hot flashes and other symptoms ... of hormone replacement therapy using estrogen alone, experts conclude ... therapy should be considered a very reasonable option for ...
Cached Medicine News:Health News:Commonwealth Fund Commission national health care scorecard: US scores 64 out of 100 2Health News:Commonwealth Fund Commission national health care scorecard: US scores 64 out of 100 3Health News:Commonwealth Fund Commission national health care scorecard: US scores 64 out of 100 4Health News:Commonwealth Fund Commission national health care scorecard: US scores 64 out of 100 5Health News:African-Americans more likely to donate kidney to family member 2Health News:Parents, Doctors Often Differ on Chemo for Incurable Kids 2Health News:Penn researchers demonstrate efficacy of non-Hodgkin's lymphoma vaccine 2Health News:Penn researchers demonstrate efficacy of non-Hodgkin's lymphoma vaccine 3Health News:Relationships more important than genetic ties when deciding who cares for aging family, study finds 2Health News:Hormonal Treatment of Hot Flashes Still OK for Some: Experts 2Health News:Hormonal Treatment of Hot Flashes Still OK for Some: Experts 3
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
... ECTRA II systems permit the surgeon to ... endoscopically, allowing access via two portals for ... lens fogging with good air flow. ECTRA ... control. ECTRA knives permit the surgeon to ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Medicine Products: